Bioanalytical Systems Operating Income 2006-2018 | BASI

Bioanalytical Systems annual/quarterly operating income history and growth rate from 2006 to 2018. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Bioanalytical Systems operating income for the quarter ending June 30, 2018 was $0.000B, a 109.5% decline year-over-year.
  • Bioanalytical Systems operating income for the twelve months ending June 30, 2018 was $0.000B, a 142.43% decline year-over-year.
  • Bioanalytical Systems annual operating income for 2017 was $0.001B, a 142.04% decline from 2016.
  • Bioanalytical Systems annual operating income for 2016 was $-0.003B, a 434.43% decline from 2015.
  • Bioanalytical Systems annual operating income for 2015 was $0.001B, a 172.16% increase from 2014.
Bioanalytical Systems Annual Operating Income
(Millions of US $)
2017 $1
2016 $-3
2015 $1
2014 $0
2013 $1
2012 $-6
2011 $1
2010 $-2
2009 $-4
2008 $3
2007 $4
2006 $-2
2005 $1
Bioanalytical Systems Quarterly Operating Income
(Millions of US $)
Q3 2018 $-0
Q2 2018 $0
Q1 2017 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $1
Q1 2016 $0
Q4 2016 $-2
Q3 2016 $-0
Q2 2016 $-0
Q1 2015 $-1
Q4 2015 $-1
Q3 2015 $2
Q2 2015 $0
Q1 2014 $0
Q4 2014 $-0
Q3 2014 $0
Q2 2014 $0
Q1 2013 $0
Q4 2013 $0
Q3 2013 $0
Q2 2013 $-0
Q1 2012 $0
Q4 2012 $-2
Q3 2012 $-1
Q2 2012 $-2
Q1 2011 $-1
Q4 2011 $-0
Q3 2011 $0
Q2 2011 $1
Q1 2010 $1
Q4 2010 $-0
Q3 2010 $1
Q2 2010 $-1
Q1 2009 $-1
Q4 2009 $0
Q3 2009 $-1
Q2 2009 $-2
Q1 2008 $-2
Q4 2008 $-1
Q3 2008 $1
Q2 2008 $1
Q1 2007 $1
Q4 2007 $1
Q3 2007 $1
Q2 2007 $1
Q1 2006 $1
Q4 2006 $-0
Q3 2006 $-2
Q2 2006 $1
Q1 2005 $-1
Q4 2005 $0
Q3 2005 $1
Q2 2005 $-1
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.014B $0.024B
Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $98.007B 22.84
Intuitive Surgical (ISRG) United States $60.818B 59.84
Edwards Lifesciences (EW) United States $32.022B 34.27
Fresenius Medical Care AG KGaA (FMS) Germany $24.559B 16.63
ABIOMED (ABMD) United States $18.249B 131.12
IDEXX Laboratories (IDXX) United States $17.865B 51.03
DexCom (DXCM) United States $13.279B 0.00
Teleflex (TFX) United States $12.226B 27.75
Hologic (HOLX) United States $11.369B 18.65
Varian Medical Systems (VAR) United States $10.928B 27.07
STERIS (STE) United Kingdom $10.170B 26.98
Masimo (MASI) United States $6.120B 39.69
LivaNova (LIVN) United Kingdom $5.784B 37.13
Penumbra (PEN) United States $5.182B 312.92
Globus Medical (GMED) United States $5.095B 32.01
Integra LifeSciences Holdings (IART) United States $4.694B 22.87
Wright Medical Group (WMGI) Netherlands $3.776B 0.00
Cantel Medical (CMD) United States $3.515B 35.41
Inogen (INGN) United States $3.171B 68.44
Integer Holdings (ITGR) United States $2.789B 23.34
Halyard Health (AVNS) United States $2.405B 21.67
Glaukos (GKOS) United States $2.139B 0.00
Tandem Diabetes Care (TNDM) United States $2.134B 0.00
OPKO Health (OPK) United States $1.730B 0.00
Mazor Robotics (MZOR) Israel $1.535B 0.00
AxoGen (AXGN) United States $1.394B 0.00
Nevro (NVRO) United States $1.264B 0.00
K2Ms (KTWO) United States $1.203B 0.00
Luminex (LMNX) United States $1.186B 42.92
Orthofix (OFIX) United States $1.167B 33.71
Tactile Systems Technology (TCMD) United States $1.157B 184.24
Pacific Biosciences Of California (PACB) United States $1.153B 0.00
CryoLife (CRY) United States $1.141B 100.10
Natus Medical (BABY) United States $1.012B 21.24
Intersect ENT (XENT) United States $0.952B 0.00
Accelerate Diagnostics (AXDX) United States $0.795B 0.00
AngioDynamics (ANGO) United States $0.794B 27.77
Mesa Laboratories (MLAB) United States $0.763B 45.14
Veracyte (VCYT) United States $0.587B 0.00
Sientra (SIEN) United States $0.533B 0.00
ViewRay (VRAY) United States $0.499B 0.00
Neuronetics (STIM) United States $0.435B 0.00
Accuray (ARAY) United States $0.434B 0.00
SI-BONE INC (SIBN) United States $0.423B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.411B 0.00
OrthoPediatrics (KIDS) United States $0.370B 0.00
Quotient (QTNT) Switzerland $0.353B 0.00
Nuvectra (NVTR) United States $0.324B 0.00
SeaSpine Holdings (SPNE) United States $0.322B 0.00
Fluidigm (FLDM) United States $0.315B 0.00
RTI Surgical (RTIX) United States $0.294B 46.30
GenMark Diagnostics (GNMK) United States $0.271B 0.00
IRadimed (IRMD) United States $0.269B 70.20
Helius Medical Technologies (HSDT) United States $0.240B 0.00
T2 Biosystems (TTOO) United States $0.224B 0.00
Pulse Biosciences (PLSE) United States $0.212B 0.00
Ekso Bionics Holdings (EKSO) United States $0.134B 0.00
Alphatec Holdings (ATEC) United States $0.126B 0.00
Second Sight Medical Products (EYES) United States $0.112B 0.00
Ra Medical Systems (RMED) United States $0.108B 0.00
Sensus Healthcare (SRTS) United States $0.106B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.104B 0.00
Apollo Endosurgery (APEN) United States $0.086B 0.00
Restoration Robotics (HAIR) United States $0.079B 0.00
Biosig Technologies (BSGM) United States $0.073B 0.00
Viveve Medical (VIVE) United States $0.073B 0.00
EDAP TMS (EDAP) France $0.070B 0.00
OBALON THERPTCS (OBLN) United States $0.046B 0.00
Vermillion (VRML) United States $0.043B 0.00
ConforMIS (CFMS) United States $0.040B 0.00
Neovasc (NVCN) Canada $0.038B 0.00
Lianluo Smart (LLIT) China $0.030B 0.00
DarioHealth (DRIO) Israel $0.030B 0.00
PAVmed (PAVM) United States $0.030B 0.00
Titan Medical (TMDI) Canada $0.028B 0.00
ReWalk Robotics (RWLK) Israel $0.024B 0.00
ENDRA Life Sciences (NDRA) United States $0.023B 0.00
Nanovibronix (NAOV) United States $0.016B 0.00
Presbia (LENS) Ireland $0.016B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
Cesca Therapeutics (KOOL) United States $0.006B 0.00
Avinger (AVGR) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.000B 0.00
Amedica (SINT) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00